Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities YMAB - Y-mAbs Therapeutics, Inc.
100 K
LAST VALUE
-96.96%
2 YEAR CAGR
-74.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR